Regeneron’s Eylea franchise remains resilient despite biosimilar competition. Read what makes REGN stock a Strong Buy despite ...

We recently published a list of 7 Most Profitable Biotech Stocks To Buy Right Now. In this article, we are going to take a ...

In this article, we will discuss the 10 Stocks Under $10 that Will Triple.

A study found that children with early-onset atopic dermatitis have a higher risk of developing uveitis and should be closely ...

Regeneron Pharmaceuticals (NasdaqGS:REGN) saw its share price decline by 10% over the past week. The recent approval of Dupixent for COPD in Japan was expected to bolster investor confidence, yet the ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Regeneron Pharmaceuticals Inc. closed 49.58% below its 52-week high of $1,211.20, which the company achieved on August 27th.

This was the stock's second consecutive day of losses.

Auburn University and the I-Stem Connectory at AU hosted the 2025 Alabama Science and Engineering Fair on Saturday, April 5.

Oppenheimer lowered the firm’s price target on Regeneron (REGN) to $925 from $950 and keeps an Outperform rating on the shares. The firm is ...

The teen is the first student from Levittown's General Douglas MacArthur High School to be named a finalist in the ...